Modifications of Intracranial Pressure After Molecular Adsorbent Recirculating System Treatment in Patients With Acute Liver Failure: Case Reports

Abstract Cerebral dysfunction may be fatal in patients with acute liver failure (ALF); intracranial pressure (ICP) monitoring may be mandatory to direct measures to prevent further cerebral edema. Recently the introduction of dialysis with the molecular adsorbent recirculating system (MARS) has impr...

Full description

Saved in:
Bibliographic Details
Published in:Transplantation proceedings 2007-07, Vol.39 (6), p.2042-2044
Main Authors: Pugliese, F, Ruberto, F, Perrella, S.M, Cappannoli, A, Bruno, K, Martelli, S, Celli, P, Summonti, D, D’Alio, A, Tosi, A, Novelli, G, Morabito, V, Poli, L, Rossi, M, Berloco, P.B, Pietropaoli, P
Format: Article
Language:English
Subjects:
Adolescent
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Biological and medical sciences
Brain Edema - prevention & control
Emergency and intensive care: renal failure. Dialysis management
Extracorporeal Circulation - methods
Fundamental and applied biological sciences. Psychology
Fundamental immunology
Hepatitis B - complications
Humans
Intensive care medicine
Intracranial Hypertension - etiology
Intracranial Hypertension - therapy
Intracranial Pressure
Liver Failure, Acute - etiology
Liver Transplantation
Medical sciences
Sorption Detoxification
Surgery
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Tissue, organ and graft immunology
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Cerebral dysfunction may be fatal in patients with acute liver failure (ALF); intracranial pressure (ICP) monitoring may be mandatory to direct measures to prevent further cerebral edema. Recently the introduction of dialysis with the molecular adsorbent recirculating system (MARS) has improved the outcomes among patients with ALF. The aim of this study was to evaluate ICP changes after MARS treatment among patients with ALF. Methods Three patients—14, 18 and 16 years old—were admitted to the ICU for acute liver failure induced by HBV in two cases and by acetaminophen in the other one. Because of Glasgow Coma Score (GCS)
ISSN:0041-1345
1873-2623
DOI:10.1016/j.transproceed.2007.05.061